Femoropopliteal in-stent restenosis: Current treatment strategies

Journal of Cardiovascular Surgery

Volumn 55, Issue 3, 2014, Pages 325-333

  Singh, G D ^a   Armstrong, E J ^b   Laird, J R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Endovascular procedures; Ischemia; Sents

Indexed keywords

ATHERECTOMY; CUTTING BALLOON ANGIOPLASTY; DRUG COATED BALLOON ANGIOPLASTY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; EXCIMER LASER; EXCIMER LASER ATHERECTOMY; FEMORAL ANGIOGRAPHY; FEMORAL ARTERY; FEMOROPOPLITEAL IN STENT RESTENOSIS; HUMAN; IN-STENT RESTENOSIS; NITINOL STENT; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANGIOPLASTY, BALLOON; ANIMALS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMORAL ARTERY; HUMANS; NEOINTIMA; PERIPHERAL ARTERIAL DISEASE; PLAQUE, ATHEROSCLEROTIC; PROSTHESIS DESIGN; RECURRENCE; RETREATMENT; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84901819529     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Norgen L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-67.
2. Rocha-Singh KJ, Jaff MR, Crabtree TR, Block DA, Ansel G; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007;69:910-9. (Pubitemid 46867500)
3. Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. (Pubitemid 40094743)
4. Matsumura JS, Yamanouchi D, Goldstein JA, Pollack CW, Bosiers M, Schultz GA, et al. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By using the Protégé EverfLex NitInol STent SYstem II (DURABILITY II). J Vasc Surg 2013;58:73-83.
5. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76.
6. Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M et al. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 2011;18:753-61
7. Soga Y, iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M. Midterm clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 2010;52:608-15.
8. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88. (Pubitemid 43872689)
9. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-9. (Pubitemid 46842791)
10. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012;19:1-9.
11. Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piokowski M et al. Treatment of complex atherosclerotic Popliteal artery disease with a new self-expanding interwoven nitinol stent: 12 month results of SUPERA popliteal artery stent registry. JACC Cardiovasc Interv 2013;6:65-71.
12. Yeo KK, Malik U, Laird JR. Outcomes following treatment of femoropopliteal in-stent restenosis: A single center experience. Catheter Cardiovasc Interv 2011;78:604-8.
13. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF et al. Angiographic patterns for in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8. (Pubitemid 29511140)
14. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K et al. Classification and clinical impact of restenosis after femoropopliteal stenting. Journal of the American College of Cardiology. 2012; 59: 16-23.
15. Armstrong EJ, Singh S, Singh GD, Yeo KK, Ludder S, Westin G et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long term outcomes after endovascular intervention. Catheter Cardiovasc Interv 2013: 82: 1168-74.
16. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008;248:297-302.
17. Zeller T, Rastan A, Sixt S, Schwarzwälder U, Schwarz T, Frank U et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 2006;48:1573-8. (Pubitemid 44528188)
18. Laird JR Jr, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated selfexpanding stent-grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012;80:852-9.
19. Rogers J, Laid J. Overview of new technologies for lower extremity revascularization. Circulation 2007;116:2072-85. (Pubitemid 350027514)
20. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60:1739-42.
21. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011;18:613-23.
22. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al. Paclitaxel eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011;4:495-504.
23. Sixt S, Cancino O, Treszl A, Beschorner U, Macharzina R, Rastan A et al. Drug-coated balloon angioplasty after directional atherectomy improves outcomes in restenotic femoropopliteal arteries. J Vasc Surg 2013;58:682-6.
24. Zeller T, Dake M, Tepe G, Brechtel K, Noory E, Beschorner U et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. J Am Coll Cardiol Intv 2013;6:274-1.
25. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Stenting of the superficial femoral artery: the dark sides - restenosis, clinical deterioration and fractures. J Endovasc Ther 2006;13:701-10.
26. Doomernik DE, Golchehr B, Lensvelt MM, Reijnen MM. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis. J Cardiovasc Surg (Torino) 2012;53:447-57.
27. Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol 2013;62:1320-7.
28. Gorgani F, Telis A, Narakathu N, Labarbera M, Babaev A. Long-term outcomes of the viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery. J Invasive Cardiol 2013;25:670-4.
29. Al Shammeri O, Bitar F, Ghitelman J, Soukas PA. Viabahn for femoropopliteal in-stent restenosis. Ann Saudi Med 2012;32:572-82.
30. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S et al.; ISAR-DESIRE 3 investigators. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013;381:461-7.
31. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
32. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: The DEBATE-ISR Study. J Endovasc Ther 2014;21:1-8.
33. FAIR Trial Compares DEB Versus PTA for Treating SFA In-Stent Restenosis. (2014, Jan 30). Endovascular Today. [2014 February 18]. Available at: http://evtoday.com/2014/01/fair-trial-compares-deb-versus-pta-for-treating-sfa- in-stent-restenosis
34. Topaz O, Bernardo NL, Shah R, McQueen RH, Desai P, Janin Y et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol 2001;87:849-55. (Pubitemid 32244203)
35. Topaz O, Minisi AJ, Bernardo NL, McPherson RA, Martin E, Carr SL et al. Alternations of platelet aggregation kinetics with ultraviolet laer emission: the "stunned platelet" phenomenon. Thromb Haemost 2001;86:1087-93. (Pubitemid 32975837)
36. Spectranetics' PATENT results support laser atherectomy to treat peripheral in-stent restenosis. Endovascular today. [2013 December 30]. Available at: http://evtoday.com/2013/01/spectranetics-patent-results-support- laser-atherectomy-to-treat-peripheral-in-stent-restenosis
37. Schammas NW, Shammas GA, Hafez A, Kelly R, Reynolds E, Shammas AN. Safety and one-year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopltiteal arteries: a retrospective review from a single center. Cardiovascular Revascularization Medicine 2012;13:341-4.
38. EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis - THE EXCITE ISR TRIAL. Spectrenetics Corporation. [2013 December 30]. Available at: http://www.spectranetics.com/ patients/pad-peripheral-artery-disease/clinical-trial-enrollment/
39. McKenna CJ, Wilson SH, Camrud AR, Berger PB, Holmes DR Jr, Schwartz RS. Neointimal response following rotational atherectomy compared to balloon angioplasty in a procine model of coronary in-stent restenosis. Cathet Cardiovasc Diagn 1998;45:332-6. (Pubitemid 28503356)
40. Trentmann J, Charalambous N, Djawanscer M, Schaefer JP, Jahnke T. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg 2010;51:551-60.
41. Schammas NW, Shammas GA, Helou TJ, Voelliger CM, Mrad L, Jerin M. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med 2012;13:224-7.
42. Van Den Berg JC, Pedrotti M, Canevascini R, Chimchila Chevili S, Ciovannacci L, Rosso R. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg (Torino) 2012;53:215-22.
43. Van den Berg JC. Laser debulking and drug-eluting balloons for in-stent restenosis: a light at the end of the tunnel? J Endovasc Ther 2013;20:815-8.
44. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-14.
45. Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions (PHOTOPAC). Clinicaltrials.gov. [2013 December 30]. Available at: http://clinicaltrials.gov/ show/NCT01298947